223 related articles for article (PubMed ID: 27259233)
1. Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT.
Mitra S; Federico L; Zhao W; Dennison J; Sarkar TR; Zhang F; Takiar V; Cheng KW; Mani S; Lee JS; Mills GB
Oncotarget; 2016 Jun; 7(26):40252-40265. PubMed ID: 27259233
[TBL] [Abstract][Full Text] [Related]
2. Loss of RAB25 Cooperates with Oncogenes in the Transformation of Human Mammary Epithelial Cells (HMECs) to Give Rise to Claudin-Low Tumors.
Joshi P; Ayyagari V; Kandel S; Modur V; Iqbal MF; Robinson K; Gao J; Rao K
Biomed Res Int; 2024; 2024():8544837. PubMed ID: 38803515
[TBL] [Abstract][Full Text] [Related]
3. Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin.
Jeong BY; Cho KH; Jeong KJ; Park YY; Kim JM; Rha SY; Park CG; Mills GB; Cheong JH; Lee HY
Exp Mol Med; 2018 Jan; 50(1):e435. PubMed ID: 29371698
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling.
Zhang J; Wei J; Lu J; Tong Z; Liao B; Yu B; Zheng F; Huang X; Chen Z; Fang Y; Li B; Chen W; Xie D; Luo J
Carcinogenesis; 2013 Oct; 34(10):2401-8. PubMed ID: 23722651
[TBL] [Abstract][Full Text] [Related]
5. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.
Cheng KW; Lahad JP; Kuo WL; Lapuk A; Yamada K; Auersperg N; Liu J; Smith-McCune K; Lu KH; Fishman D; Gray JW; Mills GB
Nat Med; 2004 Nov; 10(11):1251-6. PubMed ID: 15502842
[TBL] [Abstract][Full Text] [Related]
6. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25.
Yin C; Mou Q; Pan X; Zhang G; Li H; Sun Y
Thorac Cancer; 2018 Apr; 9(4):472-479. PubMed ID: 29524309
[TBL] [Abstract][Full Text] [Related]
7. Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer.
Shahabi A; Naghili B; Ansarin K; Montazeri M; Dadashpour M; Zarghami N
Asian Pac J Cancer Prev; 2021 Jan; 22(1):305-313. PubMed ID: 33507713
[TBL] [Abstract][Full Text] [Related]
8. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
9. ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition.
Skrypek N; Bruneel K; Vandewalle C; De Smedt E; Soen B; Loret N; Taminau J; Goossens S; Vandamme N; Berx G
Epigenetics Chromatin; 2018 Nov; 11(1):70. PubMed ID: 30445998
[TBL] [Abstract][Full Text] [Related]
10. Rab25 and RCP in cancer progression.
Cho KH; Lee HY
Arch Pharm Res; 2019 Feb; 42(2):101-112. PubMed ID: 30761451
[TBL] [Abstract][Full Text] [Related]
11. Rab25 in cancer: a brief update.
Mitra S; Cheng KW; Mills GB
Biochem Soc Trans; 2012 Dec; 40(6):1404-8. PubMed ID: 23176489
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of Rab25 in breast cancer correlates with lymphatic metastasis.
Yin YX; Shen F; Pei H; Ding Y; Zhao H; Zhao M; Chen Q
Tumour Biol; 2012 Oct; 33(5):1581-7. PubMed ID: 22644676
[TBL] [Abstract][Full Text] [Related]
13. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
14. Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity.
Mezencev R; Matyunina LV; Jabbari N; McDonald JF
BMC Cancer; 2016 Mar; 16():236. PubMed ID: 26988558
[TBL] [Abstract][Full Text] [Related]
15. Claudin-7 expression induces mesenchymal to epithelial transformation (MET) to inhibit colon tumorigenesis.
Bhat AA; Pope JL; Smith JJ; Ahmad R; Chen X; Washington MK; Beauchamp RD; Singh AB; Dhawan P
Oncogene; 2015 Aug; 34(35):4570-80. PubMed ID: 25500541
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor function of Rab25 in triple-negative breast cancer.
Cheng JM; Volk L; Janaki DK; Vyakaranam S; Ran S; Rao KA
Int J Cancer; 2010 Jun; 126(12):2799-812. PubMed ID: 19795443
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Staining for Ras-Related Protein 25 (RAB25) Associates with Luminal B Breast Cancer Subtype.
Belhadj A; Addou-Klouche L; Bouakline I; Medjamia M; Benammar HJ; Sahraoui T
Gulf J Oncolog; 2020 Jan; 1(32):26-33. PubMed ID: 32342915
[TBL] [Abstract][Full Text] [Related]
18. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer.
Vuoriluoto K; Haugen H; Kiviluoto S; Mpindi JP; Nevo J; Gjerdrum C; Tiron C; Lorens JB; Ivaska J
Oncogene; 2011 Mar; 30(12):1436-48. PubMed ID: 21057535
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional analysis of FIP2 binding to the endosome-localised Rab25 GTPase.
Lall P; Horgan CP; Oda S; Franklin E; Sultana A; Hanscom SR; McCaffrey MW; Khan AR
Biochim Biophys Acta; 2013 Dec; 1834(12):2679-90. PubMed ID: 24056041
[TBL] [Abstract][Full Text] [Related]
20. Rab25 regulates integrin expression in polarized colonic epithelial cells.
Krishnan M; Lapierre LA; Knowles BC; Goldenring JR
Mol Biol Cell; 2013 Mar; 24(6):818-31. PubMed ID: 23345591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
